Calquence 100 mg hard capsules clinical trials
4 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3b, Multicenter, Open-Label, Single-Arm Study of Acalabrutinib (ACP-196) in Subjects with Chronic Lymphocytic Leukemia
This study is looking at a new medicine called Calquence for people with chronic lymphocytic leukemia. Researchers want to see how safe the medicine is by tracking any side effects. They will also check if it helps people get better.
For: Chronic lymphocytic leukemiaNorway · Sweden · Denmark - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2 Multicenter Study Evaluating the Efficacy of KTE-X19 in Subjects with Relapsed/Refractory Mantle Cell Lymphoma (ZUMA-2)
This study is looking at a new treatment called KTE-X19 for a type of cancer called Mantle Cell Lymphoma. It's for people whose cancer has come back or hasn't responded to previous treatments. Researchers want to see how well the new treatment shrinks the cancer.
For: Relapsed/Refractory Mantle Cell LymphomaFrance · Spain · Germany - Ongoing, recruitingTherapeutic exploratory (Phase II)
CLL-Frail - A prospective, multicenter phase II trial of acalabrutinib in very old (≥80y) or frail CLL-Patients
This study looks at a medicine called Calquence for older or weaker patients with a type of blood cancer called CLL. It's for people who haven't had treatment before or whose cancer has come back. We want to see how well the medicine works after about six months.
For: treatment-naïve or relapsed/refractory chronic lymphocytic leukemiaAustria · Germany - Ongoing, recruitingTherapeutic exploratory (Phase II)
An Open-label, Phase 2 Study of ACP-196 in Subjects with Mantle Cell Lymphoma
This study looks at a new drug, Calquence, for adults with a type of blood cancer called Mantle Cell Lymphoma. Researchers want to see how many people respond to the treatment and how safe it is.
For: Mantle Cell LymphomaPoland · France